Forbion invests in transformative biotech and sustainability-driven companies that deliver measurable societal and environmental impact alongside financial returns. Their BioEconomy fund targets planetary health challenges (e.g., food security, circular materials), while their core biotech focus accelerates breakthrough therapies. With a 20-year track record, they prioritize investments with dual objectives: scientific/financial success and positive societal/planetary outcomes.
Bevorzugte Reifephase für die erste Finanzierung.
Groundbreaking biotech innovations and sustainable solutions that improve human and planetary health, including drug development, sustainable food/agriculture, materials, and environmental technologies.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
